| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 193 | 624 | 1,003 | 843 | | Selling General and Administrative | 289 | 1,774 | 602 | 693 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1 | 1 | 1 | 1 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (484) | (2,399) | (1,605) | (1,537) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 0 | 1 | 2 | 17 | | Earnings Before Interest And Taxes | (483) | (2,399) | (1,604) | (1,521) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (483) | (2,399) | (1,604) | (1,521) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (483) | (2,399) | (1,604) | (1,521) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (483) | (2,399) | (1,604) | (1,521) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($483) | ($2,399) | ($1,604) | ($1,521) |
|
1.27% Nasdaq 
Income Statement
